MedPath

The comparison between Capsella bursa-pastoris and mefenamic acid on bleeding rate, menstrual pain in copper T IUD users in women referred to health centers of Ardabil

Not Applicable
Conditions
terine Bleeding.
Abnormal Uterine and Vaginal bleeding Unspecified
Registration Number
IRCT201412063027N26
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Women aged 18 to 40 years old; Passing at least 3 months from IUD insertion; Heavy bleeding in menstrual cycles Due to the IUD insertion; Having regular menstrual cycles before IUD insertion; without disorders of the mefenamic acid consumption; Desire to participation in the study; Being literate

Exclusion Criteria

Known uterine fibroids and other pathologies; Hypothyroid; Hyperthyroid; Coagulation problems and known diabetes.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of menstrual bleeding. Timepoint: Before intervention, 1, 2 and 3 months after intervention. Method of measurement: Hygam chart.;The duration of menstrual bleeding. Timepoint: Before intervention, 1, 2 and 3 months after intervention. Method of measurement: Hygam chart.;Severity of Menstrual pain. Timepoint: Before intervention, 1, 2 and 3 months after intervention. Method of measurement: VAS.
Secondary Outcome Measures
NameTimeMethod
Female sexual function. Timepoint: Before intervention and 3 months after intervention. Method of measurement: FSFI questionnaire.;Adverse events. Timepoint: 1, 2 and 3 months after intervention. Method of measurement: Checklist.
© Copyright 2025. All Rights Reserved by MedPath